Medistim ASA Statistics

Total Valuation

Medistim ASA has a market cap or net worth of NOK 2.84 billion. The enterprise value is 2.72 billion.

Market Cap	2.84B
Enterprise Value	2.72B

Important Dates

The next estimated earnings date is Friday, March 21, 2025.

Earnings Date	Mar 21, 2025
Ex-Dividend Date	n/a

Share Statistics

Medistim ASA has 18.31 million shares outstanding. The number of shares has increased by 0.17% in one year.

Current Share Class	n/a
Shares Outstanding	18.31M
Shares Change (YoY)	+0.17%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	9.98%
Owned by Institutions (%)	84.98%
Float	12.33M

Valuation Ratios

The trailing PE ratio is 27.93 and the forward PE ratio is 24.72.

PE Ratio	27.93
Forward PE	24.72
PS Ratio	5.24
PB Ratio	7.01
P/TBV Ratio	8.26
P/FCF Ratio	28.29
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 18.12, with an EV/FCF ratio of 27.10.

EV / Earnings	26.75
EV / Sales	5.02
EV / EBITDA	18.12
EV / EBIT	21.33
EV / FCF	27.10

Financial Position

The company has a current ratio of 4.82, with a Debt / Equity ratio of 0.02.

Current Ratio	4.82
Quick Ratio	2.75
Debt / Equity	0.02
Debt / EBITDA	0.05
Debt / FCF	0.07
Interest Coverage	844.30

Financial Efficiency

Return on equity (ROE) is 25.95% and return on invested capital (ROIC) is 20.05%.

Return on Equity (ROE)	25.95%
Return on Assets (ROA)	16.50%
Return on Capital (ROIC)	20.05%
Revenue Per Employee	3.59M
Profits Per Employee	673,106
Employee Count	151
Asset Turnover	1.12
Inventory Turnover	0.75

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -33.92% in the last 52 weeks. The beta is 0.95, so Medistim ASA's price volatility has been similar to the market average.

Beta (5Y)	0.95
52-Week Price Change	-33.92%
50-Day Moving Average	153.41
200-Day Moving Average	171.03
Relative Strength Index (RSI)	51.29
Average Volume (20 Days)	4,373

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Medistim ASA had revenue of NOK 541.82 million and earned 101.64 million in profits. Earnings per share was 5.55.

Revenue	541.82M
Gross Profit	427.60M
Operating Income	127.49M
Pretax Income	132.34M
Net Income	101.64M
EBITDA	141.67M
EBIT	127.49M
Earnings Per Share (EPS)	5.55

Full Income Statement

Balance Sheet

The company has 127.32 million in cash and 7.47 million in debt, giving a net cash position of 119.85 million or 6.54 per share.

Cash & Cash Equivalents	127.32M
Total Debt	7.47M
Net Cash	119.85M
Net Cash Per Share	6.54
Equity (Book Value)	405.07M
Book Value Per Share	22.12
Working Capital	295.78M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 116.74 million and capital expenditures -16.40 million, giving a free cash flow of 100.34 million.

Operating Cash Flow	116.74M
Capital Expenditures	-16.40M
Free Cash Flow	100.34M
FCF Per Share	5.48

Full Cash Flow Statement

Margins

Gross margin is 78.92%, with operating and profit margins of 23.53% and 18.76%.

Gross Margin	78.92%
Operating Margin	23.53%
Pretax Margin	24.42%
Profit Margin	18.76%
EBITDA Margin	26.15%
EBIT Margin	23.53%
FCF Margin	18.52%

Dividends & Yields

This stock pays an annual dividend of 4.50, which amounts to a dividend yield of 3.00%.

Dividend Per Share	4.50
Dividend Yield	3.00%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	9
Payout Ratio	80.85%
Buyback Yield	-0.17%
Shareholder Yield	2.83%
Earnings Yield	3.58%
FCF Yield	3.53%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a